Clinical trial of a new anti-anginal drug: 2-benzofuryl-p-chlorophenyl carbinol (clobenfurol)
Abate, G.; Cuccurullo, F.; Curti, A.
Minerva Cardioangiologica 21(2): 145-153
1973
ISSN/ISBN: 0026-4725 PMID: 4572419 Document Number: 69447
Document emailed within 1 workday
Related Documents
Sun, Y. 1984: Clinical phase i trial of a new anti-neoplastic drug--glyciphosphoramide Zhonghua Zhong Liu Za Zhi 6(4): 293-295Ginestes, J. 1981: Anti-arrhythmic and anti-anginal properties of amiodarone in ambulatory therapy Annales de Cardiologie et d'Angeiologie 30(7): 529-533
Zunnunov, Z.R. 2010: Potentiation of anti-ischemic and anti-anginal action of nitrates by hydrogen sulfide balneotherapy in patients with angina of effort Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1: 11-14
Guarino, V.; Federico, P.; Telesco, R.; Varriale, A. 1974: Clinical testing of 2-benzofuryl-p-chlorophenylcarbinol Minerva Cardioangiologica 22(5): 323-331
Antalóczy, Z.; Kékes, E. 1992: Anti-anginal effect of Tenormin (atenolol) Therapia Hungarica 40(2): 58-63
Furkalo, N.K.; Zaĭtseva, V.I. 1984: Mechanisms of the anti-anginal effect of obzidan Kardiologiia 24(6): 73-76
Hubin, P. 1970: Viewpoint of the psychosomaticist on anginal and pseudo-anginal pain Revue Medicale de Liege 25(21): 703-705
Ashok, B.T.; Chen, Y.G.; Liu, X.; Garikapaty, V.P.S.; Seplowitz, R.; Tschorn, J.; Roy, K.; Mittelman, A.; Tiwari, R.K. 2002: Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 11 Suppl. 2: S86-S93
Zhu, W.; Yang, G.-y.; Zhang, Q.-x.; Li, J.-t.; Li, W.-x. 2009: Effects of indole-3-carbinol on the outcome of tumor and the changes of anti-oxidative system in null mice grafted with nasopharyngeal carcinoma Zhonghua Yu Fang Yi Xue Za Zhi 43(10): 885-889
Pavelescu, M.; Gafiţanu, E.; Dăneţ, R.; Sunel, V. 1984: Antipyretic activity of a new anti-inflammatory thiazole compound 2-(4-chlorophenyl)-thiazo-4-yl ethyl acetate in rats Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 88(3): 551-553
Brooks, R.R.; Miller, K.E.; Pelosi, S.S.; Pong, S.F.; Anthony, D.R.; Goldenberg, M.M. 1988: Characterization of 5-[5-(4-chlorophenyl-2-furanyl)]dihydro-2(3H)-furanone as a nonsteroidal antiinflammatory drug Arzneimittel-Forschung 38(1): 59-65
Mazurov, A.V.; Leĭtin, V.L.; Repin, V.S. 1984: Inhibition of thrombocyte spreading and the formation of thrombus-like aggregates bound with substrate by the anti-anginal agent trapidil Voprosy Meditsinskoi Khimii 30(4): 110-116
Adamian, K.G.; Asatrian, M.A.; Oganesian, L.S.; Grigorian, N.K.; Akopian, B.R. 1985: Effect of anti-anginal therapy on the functional state of the myocardium in patients with chronic ischemic heart disease Kardiologiia 25(9): 52-55
Marino, L.; Baroni, G.; Riccardi, A.; Franchi, M. 1982: Controlled trial of a prostaglandin-inhibiting, non-steroid, anti-inflammatory drug in primary dysmenorrhea Minerva Ginecologica 34(10): 791-796
Cosnier, D.; Duchenne-Marullaz, P.; Rispat, G.; Streichenberger, G. 1977: Cardiovascular pharmacology of bepridil (1[3 isobutoxy 2 (benzylphenyl) amino] propyl pyrrolidine hydrochloride) a new potential anti-anginal compound Archives Internationales de Pharmacodynamie et de Therapie 225(1): 133-151
Oelschläger, H.; Sengün, F.I. 1974: Polarographic determination of lorazepam (7-chloro-1,3-dihydro-3-hydroxy-5-o-chlorophenyl-2H-1,4-benzodiazepin-2-one). 16. Drug analyses using polarography or oscillopolarography Die Pharmazie 29(12): 770-773
Chourashy, B.K. 1988: Anti-anginal drugs: calcium channel blockers, beta-adrenergic blockers and nitrates Journal of the Indian Medical Association 86(10): 274-276
Agrawal, N.M.; Roth, S.; Graham, D.Y.; White, R.H.; Germain, B.; Brown, J.A.; Stromatt, S.C. 1991: Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial Annals of Internal Medicine 115(3): 195-200
Silingardi, V.; Renzi, R.; Mora, A.; Di Prisco, A.U. 1973: Clinical evaluation of the therapeutic activity of the -pyridyl-carbinol ester of clofibric acid Minerva Medica 64(16): 751-769
Spinner, D.; Walter, J.; Vazquez-Gragg, M.; Bloise, T.; Stafford-Smith, M.; Faulkner, E.; Taekman, J. 2011: Php74 Clinical Trial Learning Curves Affect Outcomes Measurement, Patient Safety and Trial Success: Contributing Factors and a Potential Solution in Clinical Trial Simulation Value in Health 14(3): A24-A25